Steven H. Marshall

2.6k total citations
60 papers, 1.3k citations indexed

About

Steven H. Marshall is a scholar working on Molecular Medicine, Endocrinology and Epidemiology. According to data from OpenAlex, Steven H. Marshall has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Medicine, 22 papers in Endocrinology and 18 papers in Epidemiology. Recurrent topics in Steven H. Marshall's work include Antibiotic Resistance in Bacteria (47 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Enterobacteriaceae and Cronobacter Research (10 papers). Steven H. Marshall is often cited by papers focused on Antibiotic Resistance in Bacteria (47 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Enterobacteriaceae and Cronobacter Research (10 papers). Steven H. Marshall collaborates with scholars based in United States, Argentina and Germany. Steven H. Marshall's co-authors include Robert A. Bonomo, Susan D. Rudin, Andrea M. Hujer, Louis B. Rice, Lenore L. Carias, Michael R. Jacobs, David van Duin, Mark D. Adams, Meredith S. Wright and Keith S. Kaye and has published in prestigious journals such as Circulation Research, Biochemistry and Clinical Infectious Diseases.

In The Last Decade

Steven H. Marshall

55 papers receiving 1.3k citations

Peers

Steven H. Marshall
María F. Mojica United States
Jennifer Adams United States
Wenchi Shang United States
Steven H. Marshall
Citations per year, relative to Steven H. Marshall Steven H. Marshall (= 1×) peers Qinglan Guo

Countries citing papers authored by Steven H. Marshall

Since Specialization
Citations

This map shows the geographic impact of Steven H. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven H. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven H. Marshall more than expected).

Fields of papers citing papers by Steven H. Marshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven H. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven H. Marshall. The network helps show where Steven H. Marshall may publish in the future.

Co-authorship network of co-authors of Steven H. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Steven H. Marshall. A scholar is included among the top collaborators of Steven H. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven H. Marshall. Steven H. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blair, Kris M., Mark Warnock, Basel H. Abuaita, et al.. (2025). Acinetobacter Baumannii Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation. Circulation Research. 137(1). e1–e15. 1 indexed citations
2.
Cadena, Elsa De La, María F. Mojica, Laura J. Rojas, et al.. (2024). First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: introducing KPC-197. Microbiology Spectrum. 12(6). e0410523–e0410523. 4 indexed citations
3.
Yasmin, Mohamad, Steven H. Marshall, Liang Chen, et al.. (2024). A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 68(10). e0020824–e0020824.
4.
Jacobs, Michael R., Caryn E. Good, Ayman M. Abdelhamed, et al.. (2024). ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten. Antimicrobial Agents and Chemotherapy. 68(12). e0112724–e0112724.
5.
Jacobs, Michael R., Ayman M. Abdelhamed, Caryn E. Good, et al.. (2024). ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime. Antimicrobial Agents and Chemotherapy. 68(9). e0075124–e0075124. 6 indexed citations
6.
Vega, Ana, Adriana Jiménez, Octavio Martínez, et al.. (2024). Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-β-lactamase ( bla VIM ): infection management and molecular analysis. Antimicrobial Agents and Chemotherapy. 68(5). e0147423–e0147423. 5 indexed citations
7.
8.
Hujer, Andrea M., Steven H. Marshall, Andrew R Mack, et al.. (2023). Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam. mBio. 14(6). e0111823–e0111823. 11 indexed citations
9.
Fulton, Scott A., Jennifer Furin, Nicholas Newman, et al.. (2023). Investigating and Treating a Corneal Ulcer Due to Extensively Drug-Resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 67(7). e0027723–e0027723. 9 indexed citations
10.
Yasmin, Mohamad, Laura J. Rojas, Steven H. Marshall, et al.. (2023). Characterization of a Novel Pathogen in Immunocompromised Patients:Elizabethkingia anophelis—Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase Inhibitors. Open Forum Infectious Diseases. 10(2). ofad014–ofad014. 10 indexed citations
11.
Williams, Felicia, Steven H. Marshall, Susan D. Rudin, et al.. (2022). Multidrug-Resistant Gram-Negative Bacteria in Burn Patients. Antimicrobial Agents and Chemotherapy. 66(9). e0068822–e0068822. 13 indexed citations
12.
Hujer, Andrea M., Christopher R. Bethel, Magdalena A. Taracila, et al.. (2022). Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance. Antimicrobial Agents and Chemotherapy. 66(5). e0179021–e0179021. 14 indexed citations
13.
Kumar, Vijay, Steven H. Marshall, Krisztina M. Papp‐Wallace, et al.. (2021). Structural Characterization of Diazabicyclooctane β-Lactam “Enhancers” in Complex with Penicillin-Binding Proteins PBP2 and PBP3 of Pseudomonas aeruginosa. mBio. 12(1). 26 indexed citations
14.
Goldberg, Joel, Vijay Kumar, Daniël Hoyer, et al.. (2021). A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp.. European Journal of Medicinal Chemistry. 220. 113436–113436. 18 indexed citations
15.
Cheng, Zishuo, Christopher R. Bethel, Pei W. Thomas, et al.. (2021). Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants. Antimicrobial Agents and Chemotherapy. 65(4). 19 indexed citations
17.
Henig, Oryan, Laura J. Rojas, Michael A. Bachman, et al.. (2019). Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan. Infection Control and Hospital Epidemiology. 40(9). 1059–1062. 15 indexed citations
18.
Chen, Allie Y., Pei W. Thomas, Zishuo Cheng, et al.. (2017). Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1. Journal of Medicinal Chemistry. 60(17). 7267–7283. 128 indexed citations
19.
Rice, Louis B., Viera Laktičová, Lenore L. Carias, et al.. (2008). Transferable Capacity for Gastrointestinal Colonization inEnterococcus faeciumin a Mouse Model. The Journal of Infectious Diseases. 199(3). 342–349. 41 indexed citations
20.
Rice, Louis B., et al.. (1996). Sequences Found on Staphylococcal β-Lactamase Plasmids Integrated into the Chromosome ofEnterococcus faecalisCH116. Plasmid. 35(2). 81–90. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026